Tags:ActiveDesignDrugHealthTechLearnNetworksPlatformQuantum
Founded by Flagship Pioneering, Cellarity is the first company developing medicines through an understanding of cell behaviors. The company’s broad platform harnesses single-cell technologies and machine learning to digitize and quantify cellular behaviors, unravel the network dynamics that govern those behaviors, and generate medicines that can direct them. Cellarity is using its platform to design medicines targeting the full cellular and molecular complexity of disease, enabling a quantum leap in the success rate and speed of drug discovery.
Location: United States, Massachusetts, Cambridge
Member count: 51-200
Total raised: $121M
Founded date: 2017

Investors 1

DateNameWebsite
26.02.2021Ahren Inno...ahreninnov...

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
04.10.2022Series C$121M-finsmes.co...

Mentions in press and media 4

DateTitleDescriptionCategoryAuthorSource
07.11.2022Class of 2...From day one, Contrary’s missi...--contrary.c...
04.10.2022Cellarity ...Cellarity, a Somerville, MA-ba...USA-finsmes.co...
25.02.2021Cellarity ...New approach to drug design, c...Biotech-fiercebiot...
-Cellarity“Cellarity ”--fastfounde...